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Abstract
Background: The discovery that nitric oxide (NO) functions as a signalling molecule in the nervous system has radically
changed the concept of neuronal communication. NO induces the release of amino acid neurotransmitters but the
underlying mechanisms remain to be elucidated.
Findings: The aim of this work was to study the effect of NO on amino acid neurotransmitter release (Asp, Glu, Gly and
GABA) in cortical neurons as well as the mechanism underlying the release of these neurotransmitters. Cortical neurons
were stimulated with SNAP, a NO donor, and the release of different amino acid neurotransmitters was measured by HPLC.
The involvement of voltage dependent Na+ and Ca2+ channels as well as cGMP in its mechanism of action was evaluated.
Conclusions: Our results indicate that NO induces release of aspartate, glutamate, glycine and GABA in cortical neurons and
that this release is inhibited by ODQ, an inhibitor of soluble guanylate cyclase. Thus, the NO effect on amino acid
neurotransmission could be mediated by cGMP formation in cortical neurons. Our data also demonstrate that the Na+ and
Ca2+ voltage- dependent calcium channels are involved in the NO effects on cortical neurons.
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Introduction
Nitric oxide (NO) is a short-lived gas produced by the family of
NO synthases from the amino acid L-arginine [1]. Its identifica-
tion as a signalling molecule in the nervous system changed the
concept of neuronal communication [2]. NO is synthesized on
demand and diffuses from nerve terminals in the vicinity of the
NO producing cells. The mechanism occurs at neuronal and non-
neuronal levels and NO release has pleiotrophic effects [3–5],
suggesting that it acts as a neuromodulator and/or neurotrans-
mitter [6,7]. NO has also been implicated in behaviour, learning
and feeding [8–10]. The soluble guanylate cyclase (sGC) enzyme
has long been considered the major physiological target for
neuronal NO [11–13]. Thus, nitrergic nerve stimulation or
administration of NO donors increases intracellular cGMP
concentrations [14–18] and could enhance nitrergic effects.
NO has been shown to modify the release of several
neurotransmitters such as acetylcholine [19,20], noradrenaline
[21,22], dopamine [23], glutamate [24–27], GABA [28–30],
serotonin [31], adenosine [30], carbon monoxide [32] and opioids
[33]. Conversely, Jin et al. [34] report that the NO precursor
arginine and the NO donor SNAP reduce glutamate release from
primary afferent terminals through S-nitrosylation of voltage-
activated Ca2+ channels. On the other hand, Sistiaga et al [16]
reported that NO inhibits glutamate release in cortical neurons
stimulated with 4-aminopyridine. The mechanisms underlying in
these effects are still not fully understood. Nonetheless, the direct
S-nitrosylation of receptors, the activation of cGMP-dependent
protein phosphorylation, the regulation of neuronal energy and
the modulation of transporters are potential mechanisms affecting
neurotransmitter release [35–37]. In this study, we look into the
role of NO as a regulator of excitatory (Asp and Glu) and
inhibitory (Gly and GABA) amino acid release in cortical neurons
and the possible involvement of calcium and sodium channels on
neurotransmitter release (Glu, Asp, Gly, GABA). For this purpose,
we used SNAP, a NO donor to increase NO levels in cortical
neurons. We evaluated the levels of different neurotransmitters in
these cells (Asp, Glu, Gly, GABA) by HPLC.
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Materials and Methods
Ethics statement
Pregnant rats were obtained from the ‘‘Laboratory Animal from
the Universidad Complutense de Madrid (U.C.M)’’; Licence
number #ES280790000086. The work was also approved by the
University Animal Care Committee (C.E.A=Commite of Exper-
imental Research and Ethics) from the Universidad Complutense
de Madrid (U.C.M; form number RD # 53/2013 for research)
and it was carried out in strict accordance with Guidelines for the
Care and Use of Laboratory Animals from the European
Communities Council Directive (86/609/EEC). All surgeries were
performed under sodium pentobarbital anesthesia, and all efforts
were made to minimize suffering of animals.
Materials
Minimum Essential Eagle’s Medium (EMEM) (Bio-Whittaker),
and Foetal calf serum (FCS) were purchased from Sera-Lab
(Sussex, England). SNAP, ODQ, CPTIO, w-conotoxin GVIA (w-
CTX GVIA), verapamil and bisoxonol (bis-[1,3-diethyl-thio-
barbiturate]-trimethineoxonol), were purchased from Sigma (ST.
Louis, USA) and w-agatoxin IVA (w-AGA IVA) and TTX were
from Calbiochem (Darmstadt, Germany). Other chemicals were
research grade products from Merck (Darmstadt, Germany).
Methods
Cell isolation and culture of cortical neurons. Foetal rat
brains from the Wistar rats at 19 days of gestation (E19) were used
in the present study. Cortical neurons were obtained following a
procedure from Segal [38] with minor modifications. Isolated
neurons were suspended in EMEM containing 0.3 g/l glutamine,
3 g/l glucose, 10% foetal calf serum (FCS), 100 U/ml penicillin
and 100 mg/ml streptomycin. Cells were placed at a density of
106 cells/ml on plastic multiwell Petri dishes. These plates were
previously treated with 10 mg/ml of poly-D-lysine, to allow the
attachment of the neurons to the plates. Cortical neurons were
grown in a humidified chamber with 95% air/5% CO2 at 37uC.
After 72 hours, the culture medium was replaced by fresh medium
containing 10 mM of cytosine arabinoside to prevent glial cells
growth. Cell viability was tested by the trypan blue exclusion
method.
Glial contamination was measured following a protocol from
Figueroa et al [39] using the specific anti-GFAP antibody. Briefly,
cells were incubated for 1 h with anti-GFAP antibody diluted
1:500 in PBS at room temperature. After a further wash with PBS,
anti-rabbit IgG FITC conjugated was applied and incubated for
30 min as before. The secondary antibody was diluted 1:100 in
PBS prior to addition. After a final wash with PBS, the glial cells
were identified by flow cytometry analysis.
Under these conditions, the glial cells represented 9%63% of
the total cell population of the culture.
Measurement of amino acid secretion. The secreted
amino acids (Asp, Glu, Gly and GABA) were analysed by HPLC
performed following the procedure described by Ma´rquez and
coworkers [40]. Cells, after 10 culture days, were washed twice
with 1 ml of Locke medium. The medium was removed and cells
were stimulated for 15 min at 37uC with 0.5 ml of fresh Locke
medium containing the different SNAP concentrations indicated
in each case. After stimulation, we followed these steps: (i) the
solution containing the released amino acids were collected (ii) the
cells were lysed by adding 0.5 ml of distilled water and this
suspension, containing the unreleased neurotransmitters, was
centrifuged at 130006g for 5 min. Supernatants were collected
out.
The amino acid concentrations were determined by reverse-
phase high-performance liquid chromatography using a precol-
umn derivation with dansyl chloride and UV detection at 254 nm.
Peaks were integrated using a Spectraphysic integrator and then
quantified and compared with standards for these neurotransmit-
ters. The separation of dansyl derivatives was carried out using a
Waters Spherisorb ODS 2 column (5 mM particle size;
1560.46 cm).
Results were expressed as % of amino acid release as compared
to the total amino acid content (amino acid in the medium plus
amino acid inside the cells).
Assessment of cell viability (XTT tests). This assay is
based on the ability of live metabolically active cells to reduce
yellow tetrazolium salt (XTT) to form an orange formazan dye.
Thus, this conversion can only occur in living cells. The newly-
formed formazan dye is directly quantified using a scanning
multiwell spectrophotometer at a wavelength of 492 nm (reference
wavelength 690). The amount of orange formazan formed, as
monitored by the absorbance, directly correlates with the number
of living cells. Control and treated neurons were washed with PBS
and incubated with the XTT solution (final concentration 0.3 mg/
ml) according to Kit manufacture’s instructions. After this
incubation period, orange dye solution was spectrophotometrically
quantified. Results were expressed as percentages with respect to
the control cells, which were considered as 100%.
Measurement of the membrane potential. Changes in the
membrane potential were monitored with the fluorescent dye
bisoxonol (bis-[1, 3-diethyl-thio-barbiturate]-trimethineoxonol), a
lipophylic anion that enter cell membrane in the presence of a
depolarization. The increase of bisoxonol fluorescence indicates
membrane depolarization, thus allows more of the negatively
charged dye to enter the cells [41]. The control and treated
neurons were washed and incubated for 15 min with 0.2 mM
bisoxonol in the culture medium. We used 60 mM KCl as a
positive control for cell depolarization. After this exposure time,
the bisoxonol was removed and the neurons washed with PBS.
Fluorescence was measured at 530/25 nm excitation and 590/
20 nm emission and were monitored with a FL600-BioTek
spectrofluorimeter. Fluorescence intensity was expressed as arbi-
trary fluorescence units (AFU).
Statistical analysis
Data are shown as mean 6 SEM from either two or four
independent experiments using different cultures, each experiment
performed in triplicate with different cell batches (total 6–12
measurements/condition). Statistical analyses were made with a
One Way ANOVA on Ranks followed by the Dunn’s test. One
Way ANOVA on Ranks analyses the ‘‘normality’’ and ‘‘variance’’
of the data. If both data are passed the program uses the tests for
parametric data but if ‘‘normality or ‘‘variance’’ are failed, the
program performs the Kruskal-Wallis test. A value of p,0.05 was
considered statistically significant. Statistical analysis were per-
formed using SigmaPlot 11.0 software.
Results
SNAP action on amino acid release
Our aim was to study whether NO (SNAP) could induce amino
acid neurotransmitter release (Asp, Glu, Gly, GABA). Cortical
neuron cultures were exposed to different SNAP concentrations
(from 1 mM to 1 mM) for 15 minutes and the amino acid content
measured by HPLC in the extracellular medium as well as inside
the cells. Amino acid release was expressed as the percentage of
amino acid in the external medium in comparison to the total
Amino Acid Release by NO in Cortical Neurons
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amino acid release (outside amino acid plus that inside the cells,
which was assumed to make 100%).
The results shown in Figure 1A and 1B indicate that SNAP, at
concentration between 1 mM to 1 mM, induces release of
aspartate (Asp), glutamate (Glu), glycine (Gly) and GABA. The
Asp release increased significantly at all concentrations tested
between 10 mM to 1 mM (Figure 1A). Glutamate release
remained constant at all SNAP dosages from 10 mM up to
1 mM. The maximal release of glycine was achieved at 10 mM
SNAP and was always much higher than the basal values at all
concentrations tested up to 1 mM. (Figure 1B). On the other hand,
GABA was only released at SNAP concentrations of 1 mM
(Figure 1B). The release of these amino acids neurotransmitter was
Ca2+-dependent since SNAP had no effect in a medium without
calcium (data not show).
Action of SNAP (NO) on cell viability
As it has been demonstrated that SNAP (NO) may be toxic in
cortical neurons [42], we studied the action of 1 mM SNAP on cell
viability at different exposure times. This experiment was
performed in order to demonstrate that the amino acid
neurotransmitter release mediated by SNAP was not caused by
cellular death. Exposure times between 15 m to 24 hr were
evaluated. Results from Fig. 2 show that cortical neurons subjected
to 1 mM SNAP for 15 min to 4 hr do not present signs of lost cell
viability. However, longer SNAP exposure times induced a
progressive loss in cell viability that reached 40% at 24 hr.
Effect of carboxy-PTIO on amino acid release mediated
by SNAP (NO)
As Carboxy-PTIO is a NO scavenger molecule its action on
amino acid release mediated by SNAP (NO) was evaluated, in
order to learn the specificity of the NO effect on SNAP-mediated
amino acid release. Cortical neurones were stimulated with 1 mM
SNAP in the absence and presence of 100 mM of carboxy-PTIO
and the resulting amino acid neurotransmitter release was
measured. Results from Figure 3A show that Asp and Gly release
were inhibited in the presence of carboxy-PTIO. Similar results
were found for glutamate and GABA (Fig. 3B).
Action of guanylate cyclase on SNAP-mediated amino
acid release
Many NO actions have been attributed to guanylate cyclase. In
order to study this mechanism, ODQ, an irreversible inhibitor of
soluble guanylate cyclase (sGC), was used in the present study. We
chose 1 mM SNAP concentrations to study the possible involve-
ment of cGMP because this was the only concentration that
induced GABA release in our study. Our data showed that 10 mM
ODQ largely reversed the effect of 1 mM SNAP over the release
of all the amino acid neurotransmitters analyzed. (Figure 4). ODQ
did not significantly affect basal aspartate (Figure 4A), glutamate
(Figure 4B), glycine (Figure 4C) or GABA (Figure 4D) release.
Action of SNAP (NO) on membrane potential
Cortical neurons exposure to 1 mM SNAP for 15 minutes did
not alter the cell membrane potential. However, treatment with
60 mM KCl increased fluorescence (Figure 5). This fluorescence
confirmed the existence of KCl-mediated membrane depolariza-
Figure 1. Effect of different SNAP concentrations on: [A] aspartate and glutamate, [B] glycine and GABA release, in a medium with
calcium. The amino acid release was determined using an HPLC assay. Results are means 6 SEM of four experiments using cells from four different
cultures, each one performed in triplicate with different batches of cells (total 12 measurements/condition). Statistical significances are expressed
with respect to the respective basal release, ns = non significant and (***) = p,0.001. The basal neurotransmitter release levels were: Aspartate
= 3.260.1%, Glutamate = 2.260.3%, Glycine = 760.7% and GABA =2.360.4%.
doi:10.1371/journal.pone.0090703.g001
Figure 2. Action of 1 mM SNAP on cell viability. Cortical neurons
were exposed to 1 mM SNAP for different durations of time. After that
cellular viability was measured by the XTT assay. Results are mean-
s6SEM of two experiments from cells of different cultures, each one
performed in triplicate with different batches of cells (total 6
measurements/condition). Statistical significances were performed with
respect to the basal values. ns = no significant, * = p,0.05, ** = p,
0.01 and *** =p,0.001
doi:10.1371/journal.pone.0090703.g002
Amino Acid Release by NO in Cortical Neurons
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tion in the cortical neurons as well as the functionality of the assay
methods.
The possible role of voltage-dependent sodium and
calcium channels on SNAP-mediated amino acid release
Since SNAP (NO)-mediated release of amino acid neurotrans-
mitters is Ca2+ dependent, the involvement of the voltage-
dependent calcium channels (VDCC) on the amino acid release
mediated by 1 mM SNAP in cortical neurons was analyzed. When
the action of 1 mM SNAP was assayed in the presence of w-AGA
IVA, a blocker of P/Q VDCC, amino acid release was strongly
inhibited (Figure 6A, 6B, 6C, 6D). Similar results were obtained
with w-CTX GVIA, a blocker of N type VDCC. Nevertheless,
verapamil, a blocker of L type VDCC only inhibited glutamate
Figure 3. Action of carboxy-PTIO on amino acid release mediated by 1 mM SNAP. [A] Asp and Gly release, [B] Glu and GABA release.
Results are means6SEM of two experiments from cells of different cultures, each one performed in triplicate with different cell batches (total 6
measurements/condition). * = p,0.05; ** = p,0.01 and *** = p,0.001.
doi:10.1371/journal.pone.0090703.g003
Figure 4. Effect of ODQ, an inhibitor of soluble guanylate cyclase, on basal and amino acid release mediated by 1 mM SNAP. [A]
aspartate, [B] glutamate, [C] glycine and [D] GABA release. Results are means 6 SEM of two experiments in cells from different cultures, each one
performed in triplicate with different cell batches (total 6 measurements/condition). ns or (*) = statistical significance as compared to basal values, ns
= non significant. (***) = p,0.001; (N) statistical significance between SNAP in absence and presence of ODQ. (NN) = p,0.01 and (NNN) = p,
0.001.
doi:10.1371/journal.pone.0090703.g004
Amino Acid Release by NO in Cortical Neurons
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(Figure 6B) and glycine (Figure 6C) release without affecting
aspartate (Figure 6A) or GABA release (Figure 6D).
In addition, we ascertained whether voltage-dependent Na+
channels are involved in SNAP (NO) mediated amino acid release.
We used tetrodotoxin, (TTX), a toxin which blocks the voltage
dependent Na+ channels (VDSC). TTX inhibited the aspartate
(Figure 6A), glutamate (Figure 6B) and glycine (Figure 6C) release
induced by 1 mM SNAP. However, this toxin did not affect the
GABA release mediated by 1 mM SNAP in the cortical neurons
(Figure 6D).
Discussion
NO formed from SNAP induces amino acid
neurotransmitter release
We analyzed whether NO would trigger neurotransmitter
release in cortical neurons. Our results showed that SNAP (NO)
induces significant Asp, Glu and Gly release at SNAP concentra-
tions ranging from 10 mM to 1 mM while GABA release was only
detected at concentration of 1 mM SNAP.
This suggests that NO could regulate the balance between
excitatory and inhibitory neurotransmitters in cortical neurons by
through the levels of the NO donor SNAP. NO effects on
excitatory and inhibitory synaptic neurotransmitter release have
also been reported by several other researchers. In fact, Segieth
and co-workers [43], using NO donors, found that NO regulates
excitatory amino acid release in a biphasic manner in the
hippocampus of freely-moving rats; Horn et al. [44], demonstrated
that NO may control the activity of hypothalamic neurohypo-
phyisis neurons because these neurons also release Glu, GABA
and taurine ‘‘in vivo’’ after NO stimulation. On the other hand, in
vivo, Engelmann et al. [45], found that NO may differentially
regulate excitatory and inhibitory neurotransmitter release into the
hypothalamic supraoptic nuclei. Taken together, these observa-
tions, accompanied by our findings in cortical neurons, support the
hypothesis that SNAP (NO) could exert a differential effect on
GABA (inhibitory) as well as glutamate (excitatory) release. The
amino acid release induced by SNAP was mediated by NO
because the NO scavenger carboxy-PTIO strongly inhibited the
effects of the NO donor. SNAP-mediated amino acid release was
not the result of cell death because exposing cortical neurons to
1 mM SNAP did not produce any loss of cellular viability (death)
for at least 4 hr and our studies were performed at 15 minutes
after SNAP exposure.
Involvement of VDCCs and VDSCs in amino acid
neurotransmitter release mediated by SNAP (NO)
Our results indicate that SNAP (NO) induced neurotransmitter
release through calcium dependent mechanisms since there was no
effect in a calcium-free medium. This means that NO probably
stimulates Ca2+ entry necessary to provoke neurotransmitter
release in cortical neurons. Calcium entry could be mediated by
the action of different types of Ca2+ channels, such as voltage-
dependent calcium channels (VDCC). In fact, when VDCC were
blocked by different specific toxins, the release of all SNAP (NO)
mediated neurotransmitters was inhibited in our study; since both
AGA-toxin and conotoxin were effective, P/Q-and N-type VDCC
probably cooperate in stimulating neurotransmitter release. The
blockade of L-type VDCC by verapamil strongly reduced
glutamate and glycine release without affecting aspartate or
GABA release. This observation suggests that the L-type voltage
dependent calcium channels do not seem to be involved in Asp
and GABA release mediated by NO (SNAP), maybe because
verapamil may work in a specific cell subpopulation. Differences in
the involvement of different calcium channels in neurotransmitter
release have been reported by others. Waterman et al. [46]
indicates that parasympathetic neurons in the mouse bladder
employ different Ca2+ channels to release neurotransmitters in
these neurons. Additionally, Turner et al. [47] reported that
glutamate release from whole rat brain synaptosomes was
inhibited by v-Aga toxin but unaffected by v-CTX GIVA.
Our results on the inhibition of amino acid neurotransmitter
release by the calcium channel-blocker suggests that NO induces
calcium entry though VDCC since their blockade inhibits
neurotransmitter release in the presence of SNAP (NO).
In addition, our results also showed that when cortical neurons
were stimulated with 1 mM SNAP in the presence of TTX –a
blocker of voltage dependent Na+ channels-, there was a strong
inhibition of aspartate, glutamate and glycine release but GABA
release was unafected. TTX data may suggest that NO activates
voltage-gated Na+ channels and ensures VDCC and Ca2+-
dependent neurotransmitter release. Thus, the differential sensi-
tivity of GABA release may be related to different mechanism in
GABAergic neurons were supported it by literature data [48,49].
GABA release, resistant to Na+ channel blockade (TTX), has also
been reported by others. Bieda and Copenhage [50], using retinal
amacrine cells, found that voltage dependent Na+ blockade by
TTX partially suppressed the Glycinergic and GABAergic input in
these cells. Therefore, they concluded that amacrine cells are a cell
type that uses both dependent and independent action potentials
for light-evoked release of neurotransmitters. In addition,
Martinez Martos et al. [51] have demonstrated that the basal
GABA release in the frontal cortex of awake rats was TTX
resistant.
The activation of VDCCs and VDSC may be mediated by
sGC activation
The involvement of VDCC and VDSC in SNAP (NO) release
can suggest that 1) SNAP (NO) may induce depolarization and/or
2) SNAP (NO) directly modulates these channels through
activation of sGC. In our study, we saw no depolarization in
SNAP-treated cells. However, Mongin et al. [52] found membrane
depolarization in synaptosome preparations treated with NO
Figure 5. Action of SNAP on membrane potential. Neurons were
treated for 15 min. with bisoxonol in absence (control), or presence of
either 60 mM KCl (positive control) or 1 mM SNAP. Relative changes in
dye fluorescence reflect changes in membrane potential (See Material
and Methods). Results are means6 SEM of two experiments in neurons
from different cultures, each one performed in triplicate with different
cell batches (total 6 measurements/condition). Results are shown as
arbitrary fluorescent units (AFU). Statistical significance was expressed
as compared to the basal value. ns = non significant, (**) = p,0.01.
doi:10.1371/journal.pone.0090703.g005
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donors (sodium nitroprusside, S-nitroso-L-cysteine and hydroxyl-
amine). They attributed this plasma membrane depolarization to
decreased potassium permeability and inhibition of the sodium
pump. Although we cannot exclude the possibility that SNAP/
NO–mediated amino acid neurotransmitter release is a conse-
quence of depolarization in cortical neurons, our results, showing
the inhibitor effect of both the channel blockers and ODQ on
amino acid neurotransmitter release, suggest that formation of
cGMP is an intermediate step in the modulation of neurotrans-
mitter release via GMPc on VDCC and VDNC. Although we did
not directly measure VDCC and VDNC activity, the data
available in the literature report that several VDCC are involved
in these mechanisms [53–57].
Taken together, these findings suggest that SNAP(NO) mediates
amino acid release in cortical neurons (Figure 7): the NO formed
from the donor (SNAP) (see 1 on Fig. 7) binds to its intracellular
receptor, the soluble guanylate cyclase (sGC) activating it. The
activation of sGC forms cGMP, which may directly activate Na+
(see 2 in Fig.7) and Ca2+ voltage dependent channels (see 3 on
Fig. 7) by a mechanism which needs to be further elucidate. This
effect would promote activation of these channels and the entry of
Ca2+ (see 4 on Fig.7) and Na+ (see 5 on Fig. 7) to induce
neurotransmitter release. Finally, the increase of Ca2+ through
VDCC may be involved in this neurotransmitter release (see 4 on
Fig. 7) while the increase of Na+ via VDSC would have induced
action potentials in cortical neurons¨in vitro¨ (see 5 on Fig. 7).
The working model presented in Figure 7 is supported by
several observations from our study: 1) SNAP (NO) induces amino
acid release that is inhibited by the presence of ODQ (an inhibitor
of sGC) and 2) voltage dependent calcium channels of the types N,
Figure 6. Effect of the selective inhibitors of voltage dependent Ca2+ and Na+ channels on amino acid release mediated by
SNAP(NO). [A] aspartate release, [B] glutamate release, [C] Glycine release and [D] GABA release. The toxin concentrations used were w-Aga GIVA
(300 nM), w-CTX GVIA (5 mM) and verapamil (10 mM); Results are means 6 SEM of two experiments with cells from different cultures, each one
performed in triplicate with different cell batches (total 6 measurements/condition). ns or (*) = statistical significance as compared to basal levels,
(N) = statistical significance between SNAP in the absence and presence of the specific channel blocker; ns = non significant, (NN) = p,0.01 and
(***) or (NNN) = p,0.001.
doi:10.1371/journal.pone.0090703.g006
Figure 7. Possible mechanisms by which NO induces neuro-
transmitters release in cortical neurons. (1) Increased in NO
induces activation of sGC and, as a consequence, cGMP formation. The
increases in cGMP levels may activate VDSC (2) and VDCC (3) channels
by a mechanism which yet to be elucidated. An increase in intracellular
calcium levels (4) would be responsible for the amino acid release.
Activation of VDSC may trigger local depolarization and promote or
amplify opening of VDCC (5).
doi:10.1371/journal.pone.0090703.g007
Amino Acid Release by NO in Cortical Neurons
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P/Q and L and voltage dependent Na+ channels are involved in
the amino acid release induced by SNAP (NO).
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